Ligand validation:2A7N

FMN: FLAVIN MONONUCLEOTIDE

FMN is a Ligand Of Interest in 2A7N designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2A7N_FMN_A_390	80%	9%	0.129	0.98	2.84	1.72	15	12	2	0	100%	1
3GIY_FMN_A_900	97%	8%	0.068	0.986	2.91	1.74	15	11	2	0	100%	1
1P4C_FMN_A_490	88%	11%	0.099	0.976	2.61	1.61	14	11	1	0	100%	1
1P5B_FMN_A_490	86%	7%	0.104	0.973	3.09	1.69	14	13	2	0	100%	1
1HUV_FMN_A_390	81%	10%	0.111	0.964	2.56	1.8	13	15	4	0	100%	1
2A7P_FMN_A_390	63%	8%	0.167	0.964	2.92	1.72	15	11	2	0	100%	1
4XHF_FMN_C_300	100%	16%	0.024	0.995	2.46	1.29	11	6	0	0	100%	0.9677
1QXO_FMN_D_4004	100%	27%	0.025	0.993	1.24	1.7	2	15	1	0	100%	1
5LJI_FMN_A_201	100%	27%	0.025	0.995	1.62	1.33	5	5	0	0	100%	1
9DHH_FMN_A_401	100%	35%	0.026	0.994	1.4	1.19	5	5	0	0	100%	1
8J4W_FMN_C_201	100%	43%	0.031	0.992	1.08	1.12	2	5	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.